Edition:
United States

Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

1.94USD
29 Jul 2016
Change (% chg)

$0.03 (+1.67%)
Prev Close
$1.91
Open
$1.90
Day's High
$1.95
Day's Low
$1.80
Volume
7,333
Avg. Vol
37,157
52-wk High
$4.15
52-wk Low
$1.61

Reports per page
Select Report Title Date Provider Pgs Price
Acura Pharmaceuticals 6:53am EDT S&P Capital IQ Quantitative Report 9 104.00
Acura Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 29 Jul 2016 Reuters Investment Profile 12 20.00
Thomson Reuters Stock Report - Acura Pharmaceuticals Inc (ACUR-O) 29 Jul 2016 Thomson Reuters Stock Report 12 25.00
ACUR: Due Diligence Review: Forensic Earnings and Valuation 28 Jul 2016 New Constructs, LLC 10 25.00
ValuEngine Rating and Forecast Report for ACUR 23 Jul 2016 ValuEngine, Inc. 11 25.00
ACURA PHARMACEUTICALS INC (ACUR=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 22 Jul 2016 Pechala's Reports 2 25.00
Value Graph: ACURA PHARMACEUT -- ACUR 21 Jul 2016 Ford Investor Services, Inc. 1 12.00
Wright Investors Service Comprehensive Report for Acura Pharmaceuticals, Inc. 8 Jul 2016 Wright Reports 61 75.00
Thomson Reuters Stock Report - Acura Pharmaceuticals Inc (ACUR-O) 10 May 2016 Thomson Reuters Stock Report 12 25.00
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review 6 May 2016 GlobalData 44 300.00
 
Name Age Since Current Position

Robert Jones

56 2011 President, Chief Executive Officer, Director

Peter Clemens

62 2004 Chief Financial Officer, Senior Vice President, Secretary

Robert Seiser

51 2004 Vice President, Corporate Controller and Treasurer

J. Bradley Rivet

61 2011 Vice President - Marketing

Albert Brzeczko

58 2009 Vice President -Technical Affairs